Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Jun 12, 2026, 4:00 PM EDT
1.610
+0.050 (3.21%)
Pre-market: Jun 15, 2026, 6:52 AM EDT

Autolus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
93.676.3610.011.76.381.51
Revenue Growth (YoY)
938.74%662.52%489.79%-73.38%323.23%522.73%
Cost of Revenue
102.99104.4113.91---
Gross Profit
-9.39-28.05-3.91.76.381.51
Selling, General & Admin
145.93135.5199.4446.7534.1331.87
Research & Development
112.17113.64141.82130.48136.23110.84
Other Operating Expenses
--0.270.394.171.510.68
Total Operating Expenses
258.1248.89241.64181.4171.87143.38
Operating Income
-271.21-276.94-245.54-179.7-165.49-141.87
Interest Income
12.0922.4541.4413.5110.530.26
Interest Expense
-14.82-42.82-13.96-45.07-10.39-1.11
Other Non-Operating Income (Expense)
-1.76--2.86--0.15
Total Non-Operating Income (Expense)
-4.49-20.3727.48-28.70.14-0.99
Pretax Income
-288.36-297.3-218.06-208.4-165.35-142.04
Provision for Income Taxes
-2.98-2.1215.990.0223.37-0.06
Net Income
-285.38-295.19-234.05-208.42-188.72-141.98
Net Income to Common
-288.97-299.42-202.07-208.38-141.98-142.1
Shares Outstanding (Basic)
2662662551749572
Shares Outstanding (Diluted)
2662662551749572
Shares Change (YoY)
0.02%4.30%46.69%83.11%31.78%39.81%
EPS (Basic)
-1.09-1.13-0.79-1.20-1.50-1.97
EPS (Diluted)
-1.09-1.13-0.79-1.20-1.50-1.97
Free Cash Flow
-286.81-143.31-610.31-156.57-114.57-126.72
Free Cash Flow Per Share
-1.08-0.54-2.39-0.90-1.21-1.76
Gross Margin
-10.03%-36.73%-38.93%100.00%100.00%100.00%
Operating Margin
-289.75%-362.65%-2451.82%-10583.10%-2594.67%-9414.27%
Profit Margin
-304.89%-386.55%-2337.06%-12274.50%-2958.92%-9421.37%
FCF Margin
-306.42%-187.66%-6094.14%-9221.02%-1796.30%-8408.63%
EBITDA
-260.8-266.5-237.87-173.14-158.25-133.42
EBITDA Margin
-278.63%-348.98%-2375.23%-10196.50%-2481.18%-8853.02%
EBIT
-271.21-276.94-245.54-179.7-165.49-141.87
EBIT Margin
-289.75%-362.65%-2451.82%-10583.10%-2594.67%-9414.27%
Effective Tax Rate
1.03%0.71%-7.33%-0.01%-14.13%0.04%
SEC Filings: 10-K · 10-Q